Recent Posts on This Topic | See All >
ASU launching initiative for biomedical researchTags: arizona state university, asu biosignatures consortium, c-path, collaboration, igc
[Source: Phoenix Business Journal] - ASU is one step closer to finding cures and preventing diseases based on a person’s genetic make up.
Some of the state’s biggest bioscience players have been tapped to lead the consortium where reseachers will work to develop signature drugs and treatments for life-threatening illnesses, such as cancer.
The ASU Biosignatures Consortium Initiative’s goal is not only to diagnose illnesses, but also to predict the risk of disease. Biosignatures are unique to each patient’s age, sex, health and genetics.
For more information: ASU launching initiative for biomedical research
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.